GLP-1/GIP peptide (Tirzepatide) has also been FDA-approved for treating type-2 diabetes
It aids in the production of energy in heart cells and has been shown to improve blood flow and reduce symptoms of peripheral artery disease
It develops when the body becomes less sensitive to insulin, a hormone produced by the pancreas that allows cells to absorb glucose from the bloodstream for energy
Mechanism of Action Stimulates angiogenesis (formation of new blood vessels) Increases fibroblast activity and collagen synthesis Reduces pro-inflammatory cytokines and promotes anti-inflammatory cascades Enhances tendon-to-bone healing , muscle fiber regeneration, and gut lining repair Works through interaction with the nitric oxide system , aiding circulation and tissue oxygenation BPC157 promotes tendon and ligament healing, accelerates wound closure, and stabilizes vascular response after injury. Sikiric et al., Current Pharmaceutical Design Applications Joint pain, tendonitis, ligament tears Ulcers, IBS, leaky gut Muscle strain, post-surgical recovery Neural repair and recovery from nerve compression Post-cycle inflammation and tissue stress Delivery Administered via subcutaneous injection , near site of injury or systemically Can also be taken orally for GI-related issues (due to gastric stability) BPC157 Overview and How It Works BPC157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice
Does tirzepatide come in pill form
Follow-up was divided into 8-week intervals after the first dose was dispensed
